Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nancy Maltez

Showing results (21-30 of 32) with videos related to

Pageof 4
Sort By:
Cancer Immunology, Immunotherapy : CII|January 20, 2021
Preexisting autoimmune disease and immune-related adverse events associated with anti-PD-1 cancer immunotherapy: a national case series from the Canadian Research Group of Rheumatology in Immuno-OncologySabrina Hoa, Linda Laaouad, Janet Roberts, et al.
Seminars in Arthritis and Rheumatism|October 1, 2023
Non-surgical local treatments of digital ulcers in systemic sclerosis: a systematic literature reviewCorrado Campochiaro, Yossra A Suliman, Michael Hughes, et al.
Rheumatology (Oxford, England)|June 19, 2023
Systemic pharmacological treatment of digital ulcers in systemic sclerosis: a systematic literature reviewLaura Ross, Nancy Maltez, Michael Hughes, et al.
Seminars in Arthritis and Rheumatism|October 12, 2023
Surgical management of digital ulcers in systemic sclerosis: A systematic literature reviewYossra A Suliman, Corrado Campochiaro, Michael Hughes, et al.
Autoimmunity Reviews|February 25, 2026
Points to consider for reporting digital ulcers in systemic sclerosis interventional studies: An initiative from the world Scleroderma Foundation digital ulcer ad hoc committeeCorrado Campochiaro, Nancy Maltez, Yossra Suliman, et al.
Rheumatology (Oxford, England)|July 11, 2025
'Am I doing this right?' Physician perceptions of the global assessment in clinical trials of systemic sclerosisHana Sabanovic, John D Pauling, Murray Baron, et al.
Journal of Scleroderma and Related Disorders|August 25, 2025
Treatment recommendations for the systemic pharmacological treatment of systemic sclerosis digital ulcers: Results from the World Scleroderma Foundation Ad Hoc CommitteeNancy Maltez, Laura Ross, Murray Baron, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|December 2, 2022
Amplification of Inflammation by Lubricin Deficiency Implicated in Incident, Erosive Gout Independent of HyperuricemiaKhaled Elsaid, Tony R Merriman, Leigh-Ana Rossitto, et al.
Journal of Scleroderma and Related Disorders|May 19, 2025
Recommendations for the local management of digital ulcers in systemic sclerosis: A report from the World Scleroderma Foundation (WSF) 'Ad hoc committee'Corrado Campochiaro, Yossra A Suliman, Dilia Giuggioli, et al.
The Journal of Rheumatology|September 15, 2025
Canadian Rheumatology Association/Canadian Research Group of Rheumatology in Immuno-Oncology Living Guidelines for Baseline Immunosuppression in Individuals With Preexisting Rheumatic Diseases Initiating Immune Checkpoint Inhibitors. Part 2: Preexisting Systemic Autoimmune Rheumatic DiseasesCarrie Ye, Roko P A Nikolic, May Choi, et al.
Pageof 4

Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
Cancer Immunology, Immunotherapy : CII|January 20, 2021
Preexisting autoimmune disease and immune-related adverse events associated with anti-PD-1 cancer immunotherapy: a national case series from the Canadian Research Group of Rheumatology in Immuno-OncologySabrina Hoa, Linda Laaouad, Janet Roberts, et al.
Seminars in Arthritis and Rheumatism|October 1, 2023
Non-surgical local treatments of digital ulcers in systemic sclerosis: a systematic literature reviewCorrado Campochiaro, Yossra A Suliman, Michael Hughes, et al.
Rheumatology (Oxford, England)|June 19, 2023
Systemic pharmacological treatment of digital ulcers in systemic sclerosis: a systematic literature reviewLaura Ross, Nancy Maltez, Michael Hughes, et al.
Seminars in Arthritis and Rheumatism|October 12, 2023
Surgical management of digital ulcers in systemic sclerosis: A systematic literature reviewYossra A Suliman, Corrado Campochiaro, Michael Hughes, et al.
Autoimmunity Reviews|February 25, 2026
Points to consider for reporting digital ulcers in systemic sclerosis interventional studies: An initiative from the world Scleroderma Foundation digital ulcer ad hoc committeeCorrado Campochiaro, Nancy Maltez, Yossra Suliman, et al.
Rheumatology (Oxford, England)|July 11, 2025
'Am I doing this right?' Physician perceptions of the global assessment in clinical trials of systemic sclerosisHana Sabanovic, John D Pauling, Murray Baron, et al.
Journal of Scleroderma and Related Disorders|August 25, 2025
Treatment recommendations for the systemic pharmacological treatment of systemic sclerosis digital ulcers: Results from the World Scleroderma Foundation Ad Hoc CommitteeNancy Maltez, Laura Ross, Murray Baron, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|December 2, 2022
Amplification of Inflammation by Lubricin Deficiency Implicated in Incident, Erosive Gout Independent of HyperuricemiaKhaled Elsaid, Tony R Merriman, Leigh-Ana Rossitto, et al.
Journal of Scleroderma and Related Disorders|May 19, 2025
Recommendations for the local management of digital ulcers in systemic sclerosis: A report from the World Scleroderma Foundation (WSF) 'Ad hoc committee'Corrado Campochiaro, Yossra A Suliman, Dilia Giuggioli, et al.
The Journal of Rheumatology|September 15, 2025
Canadian Rheumatology Association/Canadian Research Group of Rheumatology in Immuno-Oncology Living Guidelines for Baseline Immunosuppression in Individuals With Preexisting Rheumatic Diseases Initiating Immune Checkpoint Inhibitors. Part 2: Preexisting Systemic Autoimmune Rheumatic DiseasesCarrie Ye, Roko P A Nikolic, May Choi, et al.
Pageof 4